Parental Genetic Screening for Embryo Adoption
When the American Embryo Adoption Agency's infertile couple chooses to use high quality advanced embryos, there is a very high rate of success with those resulting blastocysts. The recipient patient might decide to proceed with Genetic carrier screening (GCS) in either parent who donated the blastocysts for many reasons.
If you’re planning a pregnancy through embryo adoption, you may want to know all you can about your blastocysts donors to determine your risk of passing on over 300 genetic diseases to your future child. However, eighty percent of children born with a genetic condition have no family history of that disease. Genetic Carrier Screening is an expanded assessment of the embryo donor’s genes that can help you plan for a healthy baby. GCS allows for a closer look at the blastocysts’ donors, to see if there is a chance your baby could inherit certain rare genetic disorders. A GCS can identify your risk for having a child with one of many hereditary disorders including cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and more. It's a simple blood test from the donor(s) that allows you to plan with self-assurance.
Testing For X Linked Recessive Inherited Disorders
Our team continually reviews the GCS to include DNA mutations that are clinically useful and can be reported with > 99.9% accuracy. Our donor’s reporting feature allows you to screen both donors at the same time and receive one combined report. See the list below showing blood potential genetic screening in patients or gamete donors which we can test.
- Lesch-Nyhan Syndrome
- Duchene Muscular Dystrophy
- Hunter's Disease
- Menkes Disease (Kinky hair syndrome)
- Glucose 6 Phosphate Dehydrogenase Deficiency
- Hemophilia A and B
- Fabry's Disease
- Wiskott-Aldrich Syndrome
- Bruton's Aggamaglobulinemia
- Color Blindness
- Complete Androgen Insensitivity
- Congenital Aqueductal stenosis (hydrocephalus)
- Inherited Nephrogenic Diabetes Insipidus